Found: 18
Select item for more details and to access through your institution.
Pharmacokinetics of Co‐Suspension Delivery Technology Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate (BGF MDI) and Budesonide/Formoterol Fumarate Dihydrate (BFF MDI) Fixed‐Dose Combinations Compared With an Active Control: A Phase 1, Randomized, Single‐Dose, Crossover Study in Healthy Adults
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 2, p. 223, doi. 10.1002/cpdd.585
- By:
- Publication type:
- Article
Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD.
- Published in:
- International Journal of COPD, 2020, v. 15, p. 43, doi. 10.2147/COPD.S223638
- By:
- Publication type:
- Article
Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA.
- Published in:
- International Journal of COPD, 2018, v. 13, p. 2969, doi. 10.2147/COPD.S171835
- By:
- Publication type:
- Article
Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD.
- Published in:
- International Journal of COPD, 2018, v. 13, p. 1187, doi. 10.2147/COPD.S159246
- By:
- Publication type:
- Article
Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD.
- Published in:
- International Journal of COPD, 2018, v. 13, p. 945, doi. 10.2147/COPD.S154988
- By:
- Publication type:
- Article
Lack of an effect of anacetrapib on the pharmacokinetics of digoxin in healthy subjects.
- Published in:
- Biopharmaceutics & Drug Disposition, 2011, v. 32, n. 9, p. 525, doi. 10.1002/bdd.776
- By:
- Publication type:
- Article
Evaluation of Methods for Estimating Time to Steady State with Examples from Phase 1 Studies.
- Published in:
- AAPS Journal, 2008, v. 10, n. 1, p. 141, doi. 10.1208/s12248-008-9014-y
- By:
- Publication type:
- Article
Lack of a meaningful effect of anacetrapib on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2012, v. 74, n. 1, p. 116, doi. 10.1111/j.1365-2125.2012.04171.x
- By:
- Publication type:
- Article
24-h bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPD.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Estimating time to steady state using the effective rate of drug accumulation.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 1, p. 27, doi. 10.1002/pst.404
- By:
- Publication type:
- Article
Pharmacokinetic drug interaction between AEE788 and RAD001 causing thrombocytopenia in patients with glioblastoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 1, p. 281, doi. 10.1007/s00280-011-1754-1
- By:
- Publication type:
- Article
Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 6, p. 579, doi. 10.1007/s40261-021-01040-7
- By:
- Publication type:
- Article
Effect of Diltiazem, a Moderate CYP3A Inhibitor, on the Pharmacokinetics of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein Inhibitor, in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 3, p. 436, doi. 10.1177/0091270010368676
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Tolerability of Phentermine in Healthy Participants Receiving Taranabant, a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 10, p. 1228, doi. 10.1177/0091270009341651
- By:
- Publication type:
- Article
Multiple Doses of Sitagliptin, a Selective DPP-4 Inhibitor, Do Not Meaningfully Alter Pharmacokinetics and Pharmacodynamics of Warfarin.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 10, p. 1157, doi. 10.1177/0091270009341653
- By:
- Publication type:
- Article
Effect of Sitagliptin on the Pharmacokinetics of Simvastatin.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 4, p. 483, doi. 10.1177/0091270008330983
- By:
- Publication type:
- Article
Multiple-Dose Pharmacokinetics, Pharmacodynamics, and Safety of Taranabant, a Novel Selective Cannabinoid-1 Receptor Inverse Agonist, in Healthy Male Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2008, v. 48, n. 6, p. 734, doi. 10.1177/0091270008317591
- By:
- Publication type:
- Article
Effect of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Blood Pressure in Nondiabetic Patients With Mild to Moderate Hypertension.
- Published in:
- Journal of Clinical Pharmacology, 2008, v. 48, n. 5, p. 592, doi. 10.1177/0091270008316885
- By:
- Publication type:
- Article